Boston-based clinical screening company receives European seal of approval for breast and ovarian cancer test
Precision Medicine Initiative calls on healthcare organisations to contribute case studies of precision medicine in action.
Study examining genes of holocaust survivors and their children shows first possible human example of epigenetic inheritance.
DNA from 9,000 women used to identify two new genetic regions associated with polycystic ovary syndrome
Investment in NGS continues as Roche add new names to their list of acquisitions.
Richard Wintle explores the history of modern genome sequencing, from the Human Genome Project to the cutthroat high throughput industry of today.
A study from NCI offers genome mapping insight in glorious 3D!
ACMG’s new Scope of Practice aims to pin down the key elements of a medical geneticist in an ever changing landscape.
The Wilson Centre, a non-partisan policy forum, interviews Public Policy Scholar Eleonore Pauwels about the benefits and risks of human genome editing.
Helix, a joint venture between Illumina, Warburg Pincus and Sutter Hill Ventures, aims to accelerate the consumer adoption of genomics.
UK study reports that pinpointing the exact genetic causes of diabetes is revolutionising patient care.
Dean Schorno, former CFO of Adaptive Technologies Corp, joins 23andMe amid plans to relaunch health-focused products.
Reprogramming damaged retinal cells to detect light again could form basis of a general gene-therapy for blindness.
Using GM yeast cells as miniature drug factories could dramatically reduce costs and improve the stability of drug manufacture.
New BBC radio series FutureProofing explores the impact of synthetic biology, with input from Jennifer Doudna and Craig Venter